Gossamer Bio, Inc. (GOSS)
NASDAQ·Healthcare·Biotechnology
$0.34
-3.13%
Mkt Cap $81.79M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 17, 2026 | $7.52M | $13.80M | +83.44% | -$0.20 | -$0.21 | -5.00% | — | — |
| Q4 2025 Nov 5, 2025 | $7.53M | $13.29M | +76.64% | -$0.19 | -$0.21 | -10.53% | — | — |
| Q3 2025 Aug 5, 2025 | $5.41M | $11.49M | +112.41% | -$0.18 | -$0.17 | +5.56% | — | — |
| Q2 2025 May 15, 2025 | $3.95M | $9.89M | +150.53% | -$0.18 | -$0.16 | +11.11% | — | — |
| Q1 2025 Mar 13, 2025 | $6.83M | $9.38M | +37.24% | -$0.17 | -$0.15 | +11.76% | — | — |
| Q4 2024 Nov 7, 2024 | $6.83M | $9.48M | +38.71% | -$0.18 | -$0.14 | +22.22% | — | — |
| Q3 2024 Aug 12, 2024 | $114.29M | $95.84M | -16.14% | $0.23 | $0.22 | -4.35% | — | — |
| Q2 2024 May 7, 2024 | — | — | — | -$0.19 | -$0.19 | +0.00% | — | — |
| Q1 2024 Mar 5, 2024 | — | $6.78M | — | -$0.20 | -$0.21 | -5.00% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.20 | -$0.21 | -5.00% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$0.49 | -$0.45 | +8.16% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$0.55 | -$0.52 | +5.45% | — | — |
| Q1 2023 Mar 17, 2023 | — | — | — | -$0.62 | -$0.59 | +4.84% | — | — |
| Q4 2022 Nov 3, 2022 | — | — | — | -$0.66 | -$0.65 | +1.52% | — | — |
| Q3 2022 Aug 9, 2022 | — | — | — | -$0.67 | -$0.74 | -10.45% | — | — |
| Q2 2022 May 10, 2022 | — | — | — | -$0.77 | -$0.76 | +1.30% | — | — |
| Q1 2022 Mar 3, 2022 | — | — | — | -$0.74 | -$0.74 | +0.00% | — | — |
| Q4 2021 Nov 8, 2021 | — | — | — | -$0.78 | -$0.80 | -2.56% | — | — |
| Q3 2021 Aug 9, 2021 | — | — | — | -$0.77 | -$0.80 | -3.90% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$0.80 | -$0.78 | +2.50% | — | — |